These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22795503)

  • 21. Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer.
    Yang Ai SS; Hsu K; Herbert C; Cheng Z; Hunt J; Lewis CR; Thomas PS
    Respir Med; 2013 Jun; 107(6):911-8. PubMed ID: 23507584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
    Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
    Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
    Suzuki M; Shigematsu H; Iizasa T; Hiroshima K; Nakatani Y; Minna JD; Gazdar AF; Fujisawa T
    Cancer; 2006 May; 106(10):2200-7. PubMed ID: 16598760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
    Tam IY; Chung LP; Suen WS; Wang E; Wong MC; Ho KK; Lam WK; Chiu SW; Girard L; Minna JD; Gazdar AF; Wong MP
    Clin Cancer Res; 2006 Mar; 12(5):1647-53. PubMed ID: 16533793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative and sensitive detection of rare mutations using droplet-based microfluidics.
    Pekin D; Skhiri Y; Baret JC; Le Corre D; Mazutis L; Salem CB; Millot F; El Harrak A; Hutchison JB; Larson JW; Link DR; Laurent-Puig P; Griffiths AD; Taly V
    Lab Chip; 2011 Jul; 11(13):2156-66. PubMed ID: 21594292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.
    Kosaka T; Yatabe Y; Endoh H; Kuwano H; Takahashi T; Mitsudomi T
    Cancer Res; 2004 Dec; 64(24):8919-23. PubMed ID: 15604253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
    Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
    Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
    Mitsudomi T; Viallet J; Mulshine JL; Linnoila RI; Minna JD; Gazdar AF
    Oncogene; 1991 Aug; 6(8):1353-62. PubMed ID: 1679529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
    Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
    Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
    Takezawa K; Okamoto I; Yonesaka K; Hatashita E; Yamada Y; Fukuoka M; Nakagawa K
    Cancer Res; 2009 Aug; 69(16):6515-21. PubMed ID: 19638574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
    Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
    Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing.
    Chong IW; Chang MY; Sheu CC; Wang CY; Hwang JJ; Huang MS; Lin SR
    Oncol Rep; 2007 Jul; 18(1):17-24. PubMed ID: 17549340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concordance in molecular genetic analysis of tumour tissue, plasma, and exhaled breath condensate samples from lung cancer patients.
    Tetik Vardarli A; Pelit L; Aldag C; Korba K; Celebi C; Dizdas TN; Uzun UC; Tayfur E; Aykut A; Karakus HS; Baysal E; Goksel O; Pelit F; Yalcin F; Ertas FN; Basbinar Y; Veral A; Gunduz C; Goksel T
    J Breath Res; 2020 Apr; 14(3):036001. PubMed ID: 32031993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients.
    Gessner C; Kuhn H; Toepfer K; Hammerschmidt S; Schauer J; Wirtz H
    Lung Cancer; 2004 Feb; 43(2):215-22. PubMed ID: 14739043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromium in exhaled breath condensate and pulmonary tissue of non-small cell lung cancer patients.
    Goldoni M; Caglieri A; Corradi M; Poli D; Rusca M; Carbognani P; Mutti A
    Int Arch Occup Environ Health; 2008 Feb; 81(4):487-93. PubMed ID: 17724608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exhaled breath condensate efficacy to identify mutations in patients with lung cancer: A pilot study.
    Kazeminasab S; Ghanbari R; Emamalizadeh B; Jouyban-Gharamaleki V; Taghizadieh A; Jouyban A; Khoubnasabjafari M
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(4):370-383. PubMed ID: 35249462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exhaled matrix metalloproteinase-9 in lung cancer.
    Carpagnano GE; Palladino GP; Martinelli D; Lacedonia D; Orlando S; Foschino-Barbaro MP
    Rejuvenation Res; 2012 Aug; 15(4):359-65. PubMed ID: 22877564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of cancer-associated mutations in exhaled breath condensates of healthy individuals by next generation sequencing.
    Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S
    Oncotarget; 2017 Mar; 8(11):18166-18176. PubMed ID: 28199989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target.
    Román M; Baraibar I; López I; Nadal E; Rolfo C; Vicent S; Gil-Bazo I
    Mol Cancer; 2018 Feb; 17(1):33. PubMed ID: 29455666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.